BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 19886337)

  • 1. Assessing cardiovascular disease in the dialysis patient.
    Baig SZ; Coats WC; Aggarwal KB; Alpert MA
    Adv Perit Dial; 2009; 25():147-54. PubMed ID: 19886337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac findings in asymptomatic chronic hemodialysis patients with persistently elevated cardiac troponin I levels.
    Katerinis I; Nguyen QV; Magnin JL; Descombes E
    Ren Fail; 2008; 30(4):357-62. PubMed ID: 18569907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic renal dysfunction as an independent risk factor for the development of cardiovascular disease.
    Varma R; Garrick R; McClung J; Frishman WH
    Cardiol Rev; 2005; 13(2):98-107. PubMed ID: 15705261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of coronary artery calcification score (CACS) for the detection of coronary artery disease (CAD) in chronic dialysis patients.
    Fujimoto N; Iseki K; Tokuyama K; Tamashiro M; Takishita S
    Clin Chim Acta; 2006 May; 367(1-2):98-102. PubMed ID: 16413522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for cardiovascular disease in patients with advanced chronic kidney disease.
    Sharma R
    J Ren Care; 2010 May; 36 Suppl 1():68-75. PubMed ID: 20586902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of interleukin-6 G-174C gene polymorphism on coronary artery disease, cardiovascular complications and mortality in dialysis patients.
    Aker S; Bantis C; Reis P; Kuhr N; Schwandt C; Grabensee B; Heering P; Ivens K
    Nephrol Dial Transplant; 2009 Sep; 24(9):2847-51. PubMed ID: 19349293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of myocardial ischemia in end-stage renal disease.
    Sharma R; Pellerin D; Brecker SJ
    Curr Opin Investig Drugs; 2007 Mar; 8(3):232-6. PubMed ID: 17408119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening and risk stratification of coronary artery disease in end-stage renal disease.
    Hakeem A; Bhatti S; Chang SM
    JACC Cardiovasc Imaging; 2014 Jul; 7(7):715-28. PubMed ID: 25034921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with end-stage renal disease and acute myocardial infarction have poor short-term outcomes despite modern cardiac intensive care.
    Cooper HA; Monge C; Panza JA
    Coron Artery Dis; 2008 Jun; 19(4):231-5. PubMed ID: 18480666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Strategy of investigation of coronary artery disease in diabetes: from screening to suspicion of acute coronary syndromes].
    Machecourt J; Vanzetto G; Fagret D
    Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 3():41-6. PubMed ID: 15666481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical approach to evaluate asymptomatic coronary artery disease in end-stage renal disease patients at the initiation of dialysis.
    Tanaka A; Sakakibara M; Asada H; Tanaka T; Ishii H; Murohara T
    Ther Apher Dial; 2014 Apr; 18(2):167-73. PubMed ID: 24720408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma elimination of cardiac troponin I in end-stage renal disease.
    Ellis K; Dreisbach AW; Lertora JL
    South Med J; 2001 Oct; 94(10):993-6. PubMed ID: 11702827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnostic and prognostic value of cardiac troponins in patients with chronic kidney disease].
    Marcinkowska E; Flisiński M; Manitius J
    Pol Merkur Lekarski; 2007 Nov; 23(137):375-81. PubMed ID: 18361324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal complications in patients receiving a solid-organ transplant.
    Diaz G; O'Connor M
    Curr Opin Crit Care; 2011 Aug; 17(4):382-9. PubMed ID: 21677579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery disease in chronic kidney disease patients: assessing the evidence for diagnosis, screening and revascularization.
    Saw J; Levin A; Gin K
    Can J Cardiol; 2004 Jun; 20(8):807-13. PubMed ID: 15229763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of cardiac biomarkers in dialysis patients.
    Wang AY; Wai-Kei Lam C
    Semin Dial; 2012 Jul; 25(4):388-96. PubMed ID: 22748194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.